OLIVE VIEW - UCLA
EDUCATION & RESEARCH INSTITUTE
2006 - 2007
Annual Report
OLIVE VIEW-UCLA MEDICAL CENTER
EDUCATION & RESEARCH INSTITUTE
BOARD OF TRUSTEES
2006 - 2007
President and Chair:
Andrew Wong, M.D.
Medicine 2B182
Extension
3205
President-elect and Vice-Chair:
Paul Schmit, M.D.
Surgery 2B156
3194
Medical Director and Exec. Secretary:
William Loos, M.D.
Med Admin 2C138
3205
Treasurer:
Paul Liu, M.D.
Pathology 1A140
4033
Hospital Administration:
Melinda Anderson / Gretchen McGinley
Hospital Administration 2C155
3001
Service Chiefs:
Rima Matevosian, M.D. - Anesthesiology 3A113
David Talan, M.D. - Emergency Medicine New Doctors Building
Dennis Cope, M.D. - Medicine 2B172
Alan Shewmon, M.D. - Neurology
Christine Holschneider, M.D. - OB-GYN (Acting)
**Paul Liu, M.D. – Pathology, 1A140
Mohammad Malekzadeh, M.D. - Pediatrics 3A108
Santwant Sidhu, M.D., Primary Care & Comm. - North Annex
Alex Kopelowicz, M.D. - Psychiatry 6D
Ramesh Verma, M.D. - Radiology & Nuclear Med. 1A140
Jesse Thompson, M.D. - Surgery 2B156
4350
3110
3205
3242
3222
4033
3233
3630
3432
4078
3194
Director of Nursing:
Marci Hamilton - Nursing 2C197
3156
Six Elected Members:
Adel El-Bialy, M.D., Cardiology/Med
Lester Jones, M.D., Surgery, 2B156
Leland Powell, M.D., Med 2B182
Maureen Simms, M.D., Pediatrics, 3A108
Robin Wachsner, M.D., Cardiology/Med
Soma Wali, M.D., Med 2B182
(2006-2009)
(2005-2008)
(2004-2007)
(2005-2008)
(2006-2009)
(2004-2007)
4289
3194
3205
3233
4289
3205
UCLA Medical Faculty Board Trustee - Inactive
Past President
Fredrick Abrahamian, D.O., Emer Med, North Annes
3110
ERI Administration: Denise Tritt
3434
July 1, 2006
Revised 04/01/07
TABLE OF CONTENTS
Executive Summary
Annual Audit
Business Office
Conferences
Indirect Costs
Institutional Review Board
Personnel
Research Awards
Revenue
Scientific Misconduct
Appendices
Board of Trustees - Treasurer’s Report
ERI Committee Lists
Overhead & Rate Data Sheet
Page
Page
Page
Page
Page
Page
Page
1
2
2
2
3
4
4
Page 5
Page 9
Page 9
Page 10
EXECUTIVE SUMMARY
The Olive View-UCLA Education & Research Institute, Inc. entered into a Medical Research
Agreement with Los Angeles County in 1981, which allowed members of the ERI to conduct
research and educational activities on the Olive View Medical Center’s premises. The Medical
Research Agreement provides that ERI shall “...seek contracts, donations, and non-County funded
grants to conduct medical research and medical education projects at Hospital and in area.”
The ERI allows physicians and related health-care personnel to engage in medical research in two
main areas: through federal and/or non-profit funded research and clinical trials. At the same
time, the past few years have seen an increase in the level of CME funds administered through
the ERI due to California Medical Association accreditation requirements.
The ERI oversees all research conducted at Olive View-UCLA Medical Center and all ValleyCare
sites. The purpose of the ERI is to stimulate professional and scientific contributions by the
members of the medical staff and to provide facilities and personnel for the performance of
medical research and education. The ERI is governed by the Board of Trustees which consist of
officers, ex-officio members, department chairs and six elected members. The Officers of the ERI
include Andrew Wong, M.D., President, Paul Schmit, M.D., President Elect, Paul Liu, M.D.,
Treasurer, and William Loos, M.D, Secretary, The Olive View-UCLA ERI’s Institutional Review
Board (IRB) assures that all research is conducted in accordance with federal, state, and county
rules and regulations. The IRB committee members complete training in human subjects and
HIPAA regulations related to research as a requirement of committee membership.
The ERI also obtains and negotiates grants and contracts with private, for-profit and government
sponsors. Sponsored research, clinical trial contracts, and other grants continue to be
administered through the ERI Business Office under the direction of the Business Manager. New
clinical studies are negotiated with the Business Manager and outside legal counsel. Finances
(including monthly reports to PI’s, quarterly reports to the Finance Committee, and the annual
audit) continue to be managed by the Accountant.
Funds managed by the ERI pay direct costs (including salary, benefits, equipment and supplies)
and indirect costs.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 1
ANNUAL AUDIT
The annual audit of the ERI was conducted in September 2006 by the firm of Kaplan, Lim and
Brignoni. The final audit report stated that all financial statements were in order and that the ERI
is in compliance with federal OMB Circular A-133.
BUSINESS OFFICE
The monthly dollar amount of payables decreased 18% from the previous fiscal year. It is noted
that fiscal years 2004-2005 and 2005-2006 included unusually large, one-time payments which
inflated the annual total. Compared to fiscal year 2003-2004, the monthly dollar amount of
payables decreased slightly by 4%. Listed below is a comparison of the dollar amount of
monthly payables since the 2003-2004 fiscal year.
PAYABLES (BY MONTH)
$85,220
2006 - 2007
$103,910
2005 - 2006
$128,826
2004 - 2005
$88,496
2003 - 2004
$0
$20,000
$40,000
$60,000
$80,000
$100,000
$120,000
$140,000
CONFERENCES
The Department of Emergency Medicine sponsored three national conferences last year. All
three conferences included lectures addressing topics in infectious disease, pediatrics, primary
care, OB-Gyn, toxicology, and critical care for emergency physicians and other health care
providers. Optional afternoon interactive ECG and emergency medicine board recertification
courses were offered at all conferences.
The first conference, entitled “19th Annual Olive View-UCLA National Conference on Advances in
Emergency Medicine and Primary Care,” was held in Las Vegas, Nevada in April 2006.
Approximately 200 people attended.
The second conference, entitled “19th Annual Olive View-UCLA National Conference on Advances
in Emergency Medicine and Primary Care,” was held in Coronado, California in July 2006.
Approximately 250 people attended.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 2
The third conference, entitled “19th Annual Olive View-UCLA National Conference on Advances in
Emergency Medicine and Primary Care,” was held in Boston, Massachusetts in October 2006.
Approximately 200 people attended.
INDIRECT COSTS
The ERI’s indirect cost rates are as follows:
Investigator Generated Protocols
Industry Sponsored Clinical Trials
Education/Service Programs
Continuing Medical Education
Gifts
21% MTDC
25% TDC
20% MTDC
15% TDC
5% Revenue
The overhead rate was successfully negotiated with DHS. The approved established rate is 21%.
The chart below shows the ERI's overhead revenue by type of funding source. The five
categories of revenue are Federal/State/Local Contracts & Grants; Clinical Trials, For Profit
Contracts & Grants, Various Research and Patient Service Funds.
2004-2005
2005-2006
2006-2007
Federal/State/Local C&G
$135,894
$145,423
$174,241
Clinical Trials
$82,872
$31,475
$58,687
For Profit C&G
$51,305
$73,102
$50,404
Various Research
$9,743
$17,302
$3,873
$522
$2,594
-$1,539
Patient Service Funds
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 3
INSTITUTIONAL REVIEW BOARD
Institutional Review Board: In 2006-2007, the amount of new projects reviewed by the
committee slightly decreased (1%). The number of renewals increased by 32% and deactivated
projects decreased slightly by 8%.
Below is a summary of activity for the past four years:
New Projects
Renewals
Deactivated
2003 - 2004
2004 - 2005
2005 - 2006
2006 - 2007
37
34
34
34
31
28
33
41
26
35
50
19
All principal investigators and key personnel are required to receive human subject and HIPAA
training regardless of funding source. Training is available through the ERI website. Tracking of
training is maintained via ERI database. Compliance is assured through initial and reminder
notification and holding IRB approval notices when necessary. In December 2006, the IRB
Administrator (Denise Tritt) completed certification training through the National Association of
IRB Managers.
PERSONNEL
At the end of the fiscal year, the ERI employed 109 employees - a slight decrease from the
previous fiscal year of 113 employees. The number of ERI personnel working on projects was 106
and the number employed by administration was three. There were 10 full time employees and
96 part time employees.
The average monthly payroll amount processed by the ERI was $89,492, an increase of 4%.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 4
Payroll (Monthly)
$100,000
$90,000
$89,492
$80,000
$85,982
$70,000
$70,413
$60,000
$50,000
$72,333
$40,000
$30,000
$20,000
$10,000
$2003-2004
2004-2005
Olive View-UCLA Education & Research Institute
2005-2006
2006-2007
2006 – 2007 Annual Report
Page 5
RESEARCH AWARDS
Listed below are the following categories of research awards: Federal/State, ERI Seed Grants,
Clinical Trials/For-Profit Awards. This does not include approved research that is sponsored by
various research funds or has no sponsor. At the close of the fiscal year, there were 86 sponsored
projects approved for research in the ERI. This represents an increase of 12% from last year’s
total of 77.
New Federal & State Awards
“Progression and Health Impacts of Parkinson’s Disease Motor and Non-Motor Manifestations
(Parkinson’s Disease quality of Life Project” – Funded by UCLA – NIH/NINDS - Charles Flippen,
M.D., Neurology
“Insulin Resistance Intervention after Stroke Trial (Yale University)” – Funded by Yale University –
NIH/NINDS - Bruce Ovbiagele, M.D. Neurology
“The Olive View Memory Disorders Program” – Funded by Unihealth Foundation - Jaime Fitten,
M.D., Psychiatry and Sheldon Wolf, M.D., Neurology
“Evaluating a Clinic-Based Program to Detect and Treat Depression Among Low-Income African
American and Latino Patients” – Funded by Robert Wood Johnson Foundation - Lacey Wyatt,
M.D., Ambulatory Medicine
On-Going Federal & State Awards
“Research to Stimulate Assessment of the Potential for the Point-of-Use (POU) and Point-of-Entry
(POE) Filters to Promote Growth of Mycobacterium avium Complex (MAC) Organisms in Potable
Water” - Funded by the Environmental Protection Agency (EPA) - Timothy Aronson, Department
of Pathology
“Rapid Identification of Key Pathogens in Wound Infections by Molecular Means” –– Robert
Bennion, M.D., Surgery - Funded by Brentwood Biomedical Research Institute/Department of
Defense. This project is in its third year.
“Pilot Feasibility Study of Trigeminal TENS for Intractable Epilepsy” – Funded by Advanced
Biologics – Christopher DeGiorgio, M.D., Neurology
“Alzheimer’s Disease Research Center - Presentation of Alzheimer’s and Vascular Dementia in
Hispanics and African Americans” - Jaime Fitten, M.D., Neurology - Funded by the State of
California/UCLA. This project is in its ninth year.
“Clinical Resource Management Disease Management Program – Phase I” – Jeff Guterman, M.D.
Funded by California Health Care Foundation.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 6
“Consented High Performance Index/Retrieval Pathology” – Funded by UCLA/NIH - Paul Liu,
M.D., Pathology
“Early Recognition of Asymptomatic Left Ventricular Dysfunction in Minority Groups” – Funded
by UCLA School of Nursing. Aurelia Macabasco-O’Connor, M.D., Nursing.
The “National Neurological AIDS Bank” project under the direction of Dr. Glenn Mathisen is in
its ninth year of funding. It is funded by the NIH NIAID/UCLA.
“Management of Coccidioidomycosis Meningitis in the Post-Fluconazole Era” – Glenn Mathisen,
M.D., Med
“Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist
(TOPCAT)” – Funded by New England Research Institute – NIH/NHLBI - Sheba Meymandi, M.D.,
Medicine/Cardiology
“Hyperspectral Imaging to Assess and Predict Diabetic Foot Ulcers” – Funded by HyperMed NIH/NIDDK – Aksone Nouvong, DPM, Dept. of Surgery.
“The Field Administration of Stroke Therapy-Mg Fast MAG” – Funded by UCLA/NIH – Vena
Ricketts, M.D., Emer Med
“Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) In
California – Heart of the Family” – Funded by the Centers for Disease Control and the State of
California - Satwant Sidhu, M.D., Ambulatory Medicine
“The Perinatal Case Management Program” (also known as Project Dream - Developing
Resources through Educational Assistance and Management). This project is a perinatal case
management program for women who abuse alcohol and/or other drugs and who also are
pregnant or have children. Project DREAM provides families with support and referrals and
services to outside agencies. Rochelle Tyler, M.D. is the Principal Investigator at Olive ViewUCLA Medical Center. The project is in its 12th and last year at Olive View.
“Emergency Department Sentinel Network for Surveillance of Emerging Infections” - Under the
direction of David Talan, M.D. and funded by the Centers for Disease Control (CDC).
Subcontracts were again issued to ten separate sites throughout the United States. The project is
in its 12th budget year at Olive View.
“Appendicitis and Protein Markers of Appendicitis” – Funded by ProteinLogic, LTD – Jesse
Thompson, M.D., Surgery
ERI Seed Grants
In September 2006 applications for Seed Grants were announced. The ERI awarded a record
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 7
number of seven seed grants this year, totaling $19,500 with funding beginning January 1, 2007.
This year’s recipients are as follows:
Jetotsna Grover, M.D., Dept. of OB/Gyn – “Outpatient versus Inpatient Use of Transcervical Foley
Catheter for Cervical Ripening – Is There a Difference?” – Amount funded: $2,000. This study will
study the effectiveness and safety of mechanical cervical ripening for induction of labor with a
transcervical foley catheter.
Timothy Jang, M.D., Dept. of Emergency Medicine – “Ultrasonographic, Non-Invasive Assessment
of Central Venous Pressure in patients with Suspected Sepsis” – Amount funded: $2,000. The
purpose of this study is to assess the accuracy of simple DEM sonography for assessing central
venous pressure and intravascular volume status in patients with suspected sepsis.
Melinda Maggard, M.D., Dept. of Surgery – “Using Quality Indicators to Improve the Care of
Breast Cancer Patients” – Amount funded: $3,500. This study will use quality indicators to
measure the quality of care delivered to breast cancer patients.
Sheba Meymandi, M.D., Dept. of Medicine (Cardiology) – Incidence of Chagas disease in
Immigrant Patients with Conduction Abnormalities on Electrocardiogram” – Amount funded:
$2,000.
This study proposes to enroll 400 individuals with RBBB, LAFB or LBBB on
electrocardiogram to determine the incidence of Chagas disease.
Aksone Nouvong, DPM, Dept. of Surgery – “Effects of Orthotics on Pregnancy-Related Changes in
Foot Morphology” – Amount funded: $3,500. This study will evaluate 100 patients, 50
randomized to receive customized orthotics and 50 control patients. Three serial scanning foot
measurements will be taken first at the onset of pregnancy, again late in the third trimester, and
finally 2-6 weeks post partum. The data will allow the investigators to determine if foot size and
shape is altered during pregnancy resulting in permanent mechanical changes, and if intervening
with orthotics to support the arch through pregnancy can prevent arch collapse with subsequent
reduced risk of developing midfoot osteoarthritis.
Michael Rotblatt, M.D., Dept. of Medicine – “Hyperlipidemia Survey for Primary Care Providers”
– Amount funded: $3,500. This study will administer a survey to primary care providers to
determine if they are utilizing NCEP guideline steps and if not, the barriers for omitting these
steps.
Christopher Tarnay, M.D., Dept. of OB/Gyn – “Sexual Function and Anatomic Outcomes in
Anterior Vaginal Reparative Surgery Using Dermal Xenograft; A Comparative Trial” – Amount
Funded: $3,000. This study will look at the impact of graft augmentation in pelvic organ
prolapse repair as it relates to sexual function and anatomic outcome.
In addition to the above, there are 13 ongoing seed grants.
Clinical Trials/For Profit Awards
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 8
During the past year, the ERI successfully negotiated six new clinical trials and for-profit awards.
They are as follows:
Fredrick Abrahamian, D.O., Emergency Medicine – “An Epidemiological Study to Evaluate the
Seasonality of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections (LRI) or
Apnea in Infants in the Emergency Department (MI-MA133)” – Funded by MedImmune, Inc.
Arthur Jeng, M.D., Medicine/Infectious Disease – “A Multicenter, Randomized, Double-Blind,
Comparison Study of the Safety and Efficacy of a Once-Daily Dose of Tigecycline vs. Ertapenem
for the Treatment of Foot Infections in Subject with Diabetes - 3074K5-319-WW” – Funded by
Wyeth Research.
Sheba Meymandi, M.D., Medicine/Cardiology – “A Double-blind, Randomized, PlaceboControlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on
Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic
Dysfunction and Anemia (#20050222)” – Funded by Amgen.
David Talan, M.D., Emergency Medicine – “Randomized, Double-Blind, Multicenter Study of
Ceftobiprole Medocaril Versus Ceftriaxone with/without Linezolid in Treatment of Subjects
Hospitalized with Community-Acquired Pneumonia” – Funded by Johnson & Johnson.
David Talan, M.D., Emergency Medicine – “An Epidemiological Study to Evaluate a Multi-marker
INdex for the Diagnosis of Sepsis in the Emergency DepartmenT (MINDSET) - Protocol Number
BSTE-0501” – Funded by Biosite.
Robin Wachsner, M.D., Medicine/Cardiology – “Lipid Treatment Assessment Project 2 (L-TAP2)
NRA 5090005” – Funded by Pfizer, Inc.
In addition to the above clinical trials, there are currently four new clinical trials in negotiation or
pending final contract approval and 40 open clinical trials.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 9
REVENUE
Included in the total revenue source is revenue earned from IRB review. The following chart
shows ERI Revenue by funding source for 2006-2007:
ERI Revenue by Source
$748,326
$800,000
$629,337
$700,000
$600,000
$498,811
$500,000
$400,000
$320,572
$268,852
$300,000
$173,509
$168,725
$200,000
$100,000
$5,948
$Sta
te/
Lo
No
n
ca
lG
ov
t
Cli
n
ica
l
-Pr
ofi
tF
Aw
ard
s
nd
Aw
ard
s
Fo
Stu
die
s
rP
rof
Fe
it C
de
ral
on
tr
ac
t&
Gr
an
Va
rio
Re
se
arc
h
ts
us
Aw
ard
s
Re
se
arc
h
Pa
tie
n
tS
erv
i
Mi
sc
.A
ce
F
un
ge
nc
ies
ds
Payment for services includes funds generated by personal services by investigators, i.e. expert
testimony, and outside contracting. At the request of the principal investigator, monies are
payable to the ERI and used for the individual investigator’s various research and or education
purposes. Total revenue for the year was $2,814,081. Last year’s revenue was $2,849,687.
SCIENTIFIC MISCONDUCT
In February 2007 the ERI filed its annual report with the Office of Research Integrity/DHHS on
possible research misconduct. No allegations were reported during the year.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 10
APPENDICES
Board of Trustees - Treasurer’s Report
ERI Committee Lists
Overhead & Rate Data Sheet
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 11
OLIVE VIEW-UCLA EDUCATION & RESEARCH INSTITUTE
BOARD OF TRUSTEES
Treasurer’s Report
RESEARCH FUNDS
2004-2005
2005-2006
2006-2007
(Revised)
(Revised)
(Preliminary)
Previous Year Unexpended Funds
$1,661,659
$1,118,567
$1,414,181 a
Current Year Revenue
Subtotal Revenue
$1,819,308
$3,480,967
$2,502,027
$3,620,594
$2,539,370 b
$3,953,551
Current Year Expenses
$2,362,400
$2,206,413
$2,113,687 c
TOTAL REVENUE LESS EXPENSE
$1,118,567
$1,414,181
$1,839,864
Previous Year Unexpended Funds
$477,772
$427,153
$416,851 d
Current Year Revenue
Expenses
$317,696
$368,315
$311,764
$322,066
$320,573 e
$323,622 f
TOTAL REVENUE LESS EXPENSE
$427,153
$416,851
$413,802
ADMINISTRATIVE FUNDS
a - carry forward from previous year column
b - revenue and expense report less admin and interdept transfers
c - revenue and expense report less admin and interdept transfers
d - carry forward from previous year column
e - report for admin
f - expense report for admin
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 12
OLIVE VIEW-MEDICAL CENTER EDUCATION AND RESEARCH INSTITUTE
RESEARCH & EDUCATION OPERATIONS COMMITTEE
2006 - 2007
Location
Extension
President:
Andrew Wong, M.D., Medicine
2B182
3205
President Elect:
Paul Schmit, M.D., Surgery
2B156
3194
Treasurer/Fin.:
Paul Liu, MD - Pathology
1A140
4033
Secretary:
William Loos, MD, - Medical Admin
2C138
3025
Clinical Operations Committee (Inactive)
Jesse Thompson, M.D. - Surgery
2B156
3194
Hospital
Azar Kattan - Hospital Admin
2C155
3005
HSPC
Anthony Shaw, M.D. - Surgery
2B156
3194
Ex-Officio:
Invited Guests*:
Fred Abrahamian, M.D., Emer Med
North Annex
Staff:
Lisa E. Gipti, Accountant
Denise Tritt, Business Manager
ERI
ERI
3434
3434
*Receives agenda only.
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 13
OLIVE VIEW-UCLA EDUCATION & RESEARCH INSTITUTE
FINANCE COMMITTEE
July 1, 2006 - June 30, 2007
Paul Liu, M.D., Chair
Pathology
1A140
4534
Andrew Wong, M.D.
Medicine
2B182
3205
Paul Schmit, M.D.
Surgery
2B156
3194
William Loos, M.D.
Medical Administration
2C138
3025
Lisa Gipti, Accountant
ERI
ERI
3434
Denise Tritt, Bus Mgr
ERI
ERI
3434
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 14
OLIVE VIEW-UCLA EDUCATION & RESEARCH INSTITUTE
HUMAN SUBJECT PROTECTION COMMITTEE - FWA 00000495
2006-2007 (April 20, 2007)
Member
Anthony Shaw, M.D.
Department
Chair
Address
Extension
One South Orange Grove, #9
Pasadena, CA 91105
(626) 796-8588
Vern Campbell, M.Div.,
Chaplain/Community Mbr
1D142
3080
Arthur Jeng, M.D.
Medicine
2B182
3205
Azar Kattan
Hospital Administration
2C155
3005
Yvette Kemhadjian, R.N.
Medical Administration
2C138
3026
Greg Moran, M.D.
Emergency Medicine
North Annex
3113
Trudy Olins, R.N.
Nursing
2C197
3168
Rita Oregon, M.D.
OB/GYN
2B163
3222
Bruce Ovbiagele, M.D.
Neurology
North Annex
3104
Alan Shewmon, M.D.
Neurology
2C136
3104
Jeanne Wallace, M.D.
Medicine
2B182
(818) 313-0551
Terry Wolfe, Ph.D.
Community Member
1503 Wildwood Drive
Los Angeles, CA 90041
(323) 258-4675
Andrew Wong, M.D.
Medicine/Rheumatology
2B182
(818) 313-1021
Staff
Research Admin Office
3434
1D102
6D129
1C101
4076
3343
3069
3A108
3233
North Annex
3242
2C199
3167
3A108
3180
Staff
Denise Tritt, CIM
Expert Consultants (As Needed)
Gail Hansen, M.D.
Radiology
Albert-Jan Kettenis, M.D.
Psychiatry
M. Salahi, M.S., M.B.A./
Pharmacy
G. Yamamoto (Consultant but receives entire packet)
Maureen Simms
Chair, Bioethics Cte.
(Consultant but receives entire packet)
Alternate Committee Members
Christopher DeGiorgio, M.D. Neurology
(for Alan Shewmon, M.D.)
Marcie Hamilton, R.N.
Nursing
(for Kathleen Battersby, R.N.)
Maureen Simms, M.D.
Pediatrics
(for C.Ewing)
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 15
Olive View-UCLA Education & Research Institute
OVERHEAD & RATE DATA SHEET
EFFECTIVE JANUARY 1, 2006
Federal TAX I.D. NO. 95-2249539
OVERHEAD RATES:
Sponsored Research:
Investigator Generated Protocols*
Industry Sponsored Clinical Trials
Education/Service Programs
21.0%** Modified Total Direct Cost***
25.0% Total Direct Cost
20.0% Modified Total Direct Cost
Continuing Medical Education (CME)
Patient Service Funds
Gifts
15.0%
15.0%
5.0%
EMPLOYEE FRINGE BENEFITS:
(including taxes)
Total Direct Cost
Total Revenue
Revenue
26% for > 75% effort
13% for < 75% effort
PER DIEM AND MILEAGE:
The ERI uses per diem & mileage rates used by the State of California. The daily per diem rate will be used when
itemized expenses are not claimed or receipts are not available. With or without receipts, the maximum per diem,
including meals, is $46. Per diem is claimed for trips of 21 hours or more.
In- & Out-of State
Daily Per Diem
Lodging
Mileage
$46.00
actual cost (for locations > 50 miles from OVMC or home-whichever is closer)
44.5 cents per mile (effective 1/1/06)
BUSINESS MEALS:
Business meals include recruitment and other situations that promote the research and education activities of the ERI.
Business meals applies only to those funds and projects that allow for such expenses. When reimbursement is
requested, a statement of the purpose of the meeting with a list of those attending and receipts are required. Alcoholic
beverages are not reimbursable.
Reimbursement is made to an ERI member or employee. The maximum reimbursable meal expenditure (including tax
and 15% tip) for each person is as follows. Charges for facility rental (if applicable) is not included.
Breakfast
Lunch
Dinner
$ 10.00
18.00
40.00
* Submitted to e.g., Public Health Service, American Cancer Society
** 22.1% is the rate established with DHHS. The actual rate charged is currently 21%.
*** excludes cost of equipment, patient care and annual subcontract costs in excess of $25,000
Olive View-UCLA Education & Research Institute
2006 – 2007 Annual Report
Page 16